Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone
Open Access
- 1 August 2000
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (8) , 1809-1819
- https://doi.org/10.1002/1529-0131(200008)43:8<1809::aid-anr17>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progressionRheumatology, 1998
- Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension studyArthritis & Rheumatism, 1997
- Molecular therapeutics. Methotrexate and its mechanism of actionArthritis & Rheumatism, 1996
- The Effectiveness of Early Treatment with “Second-Line” Antirheumatic DrugsAnnals of Internal Medicine, 1996
- Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritisThe Lancet, 1996
- Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid ArthritisNew England Journal of Medicine, 1995
- Clinical Use of Cyclosporin in Rheumatoid ArthritisDrugs, 1995
- How and When Should Combination Therapy be Used? the Role of an Anchor DrugRheumatology, 1995
- Generalised bone loss in patients with early rheumatoid arthritisThe Lancet, 1994
- The Acute-Phase Response in Relation to Radiographic Progression in Early Rheumatoid Arthritis: A Prospective Study During the First Three Years of the DiseaseRheumatology, 1993